Collectively, our findings in both the study and validation cohorts consistently show that the collagen formation markers plasma PRO-C3 and PRO-C6 increase with the different stages of liver disease, with a marked upregulation in ACLF as compared with that in AD. The gene discussed is C3; the disease is liver disorder.